Laser-induced choroidal neovascularization model to study age-related macular degeneration in mice. (Q35020040)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24136346%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

title

Laser-induced choroidal neovascularization model to study age-related macular degeneration in mice (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24136346%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

1 reference

1 reference

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24136346%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24136346%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

Eric Rozet

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24136346%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

Vincent Lambert

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24136346%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

Julie Lecomte

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24136346%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

Sylvain Hansen

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24136346%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

Silvia Blacher

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24136346%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

Maria-Luz Alvarez Gonzalez

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24136346%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

Ingrid Struman

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24136346%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

Pascal de Tullio

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24136346%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

Jean Michel Foidart

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24136346%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

Jean-Marie Rakic

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24136346%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

publication date

17 October 2013

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24136346%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24136346%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

volume

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24136346%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

issue

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24136346%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

page(s)

2197-2211

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24136346%20AND%20SRC:MED&resulttype=core&format=json

Racial variations in causes of vision loss in nursing homes: The Salisbury Eye Evaluation in Nursing Home Groups (SEEING) Study

28 February 2020

cites work

1 reference

https://api.crossref.org/works/10.1038%2FNPROT.2013.135

Age-Related Macular Degeneration

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNPROT.2013.135

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNPROT.2013.135

Tumoral and choroidal vascularization: differential cellular mechanisms involving plasminogen activator inhibitor type I.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNPROT.2013.135

Anti-angiogenic therapy of exudative age-related macular degeneration: current progress and emerging concepts

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNPROT.2013.135

Animal models of age related macular degeneration

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNPROT.2013.135

Targeted disruption of the FGF2 gene does not prevent choroidal neovascularization in a murine model

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNPROT.2013.135

VEGF-TRAP(R1R2) suppresses choroidal neovascularization and VEGF-induced breakdown of the blood-retinal barrier

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNPROT.2013.135

Intravitreal aflibercept (VEGF trap-eye) in wet age-related macular degeneration.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNPROT.2013.135

Anecortave acetate (15 milligrams) versus photodynamic therapy for treatment of subfoveal neovascularization in age-related macular degeneration

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNPROT.2013.135

MicroRNA-21 exhibits antiangiogenic function by targeting RhoB expression in endothelial cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNPROT.2013.135

Monocyte/macrophages promote vasculogenesis in choroidal neovascularization in mice by stimulating SDF-1 expression in RPE cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNPROT.2013.135

Macrophages inhibit neovascularization in a murine model of age-related macular degeneration

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNPROT.2013.135

Neural stem/progenitor cells circulating in peripheral blood of patients with neovascular form of AMD: a novel view on pathophysiology

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNPROT.2013.135

Bone marrow-derived mesenchymal cells and MMP13 contribute to experimental choroidal neovascularization

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNPROT.2013.135

Pegaptanib for the treatment of age-related macular degeneration

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNPROT.2013.135

Therapeutic anti-VEGF antibodies

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNPROT.2013.135

Further Pharmacological and Genetic Evidence for the Efficacy of PlGF Inhibition in Cancer and Eye Disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNPROT.2013.135

Placental growth factor, a member of the VEGF family, contributes to the development of choroidal neovascularization

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNPROT.2013.135

MMP-2 and MMP-9 synergize in promoting choroidal neovascularization

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNPROT.2013.135

Influence of plasminogen activator inhibitor type 1 on choroidal neovascularization

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNPROT.2013.135

Dose-dependent modulation of choroidal neovascularization by plasminogen activator inhibitor type I: implications for clinical trials

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNPROT.2013.135

Mice without uPA, tPA, or plasminogen genes are resistant to experimental choroidal neovascularization

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNPROT.2013.135

Relationship between complement membrane attack complex, chemokine (C-C motif) ligand 2 (CCL2) and vascular endothelial growth factor in mouse model of laser-induced choroidal neovascularization

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNPROT.2013.135

Role of Ocular Complement Factor H in a Murine Model of Choroidal Neovascularization

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNPROT.2013.135

Apolipoprotein E allele-dependent pathogenesis: a model for age-related retinal degeneration

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNPROT.2013.135

Drusen, choroidal neovascularization, and retinal pigment epithelium dysfunction in SOD1-deficient mice: a model of age-related macular degeneration

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNPROT.2013.135

Paracrine modulation of CXCR4 by IGF-1 and VEGF: implications for choroidal neovascularization

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNPROT.2013.135

γ-Secretase inhibition of murine choroidal neovascularization is associated with reduction of superoxide and proinflammatory cytokines.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNPROT.2013.135

Targeted intraceptor nanoparticle therapy reduces angiogenesis and fibrosis in primate and murine macular degeneration.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNPROT.2013.135

IL-27 inhibits pathophysiological intraocular neovascularization due to laser burn

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNPROT.2013.135

MicroRNA-146a is a therapeutic target and biomarker for peripartum cardiomyopathy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNPROT.2013.135

Macrophage depletion diminishes lesion size and severity in experimental choroidal neovascularization

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNPROT.2013.135

Macrophage depletion inhibits experimental choroidal neovascularization

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNPROT.2013.135

The complexity of animal model generation for complex diseases

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNPROT.2013.135

Effects of intraocular ranibizumab and bevacizumab in transgenic mice expressing human vascular endothelial growth factor

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNPROT.2013.135

Gender and estrogen supplementation increases severity of experimental choroidal neovascularization

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNPROT.2013.135

Causes of cataract development in anesthetized mice

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNPROT.2013.135

Pigment epithelium-derived factor inhibits retinal and choroidal neovascularization

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNPROT.2013.135

Suppression of Choroidal Neovascularization and Quantitative and Qualitative Inhibition of VEGF and CCL2 by Heparin

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNPROT.2013.135

Contribution of bone-marrow-derived cells to choroidal neovascularization

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNPROT.2013.135

The Role of Adult Bone Marrow-Derived Stem Cells in Choroidal Neovascularization

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNPROT.2013.135

Choroidal neovascularization is provided by bone marrow cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNPROT.2013.135

Age- and light-dependent development of localised retinal atrophy in CCL2(-/-)CX3CR1(GFP/GFP) mice.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNPROT.2013.135

Sunitinib inhibits inflammatory corneal lymphangiogenesis.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNPROT.2013.135

An animal model of age-related macular degeneration in senescent Ccl-2- or Ccr-2-deficient mice

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNPROT.2013.135

JNK inhibition reduces apoptosis and neovascularization in a murine model of age-related macular degeneration.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNPROT.2013.135

Metabolomics in noninvasive breast cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNPROT.2013.135

Metabolic signatures of esophageal cancer: NMR-based metabolomics and UHPLC-based focused metabolomics of blood serum

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNPROT.2013.135

Recent advances in metabolomics in oncology

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNPROT.2013.135

Challenges and opportunities of metabolomics

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNPROT.2013.135

Amyloid β Enhances Migration of Endothelial Progenitor Cells by Upregulating CX3CR1 in Response to Fractalkine, Which May Be Associated With Development of Choroidal Neovascularization

31 March 2020

1 reference

12 December 2020

Anecortave acetate for treating or preventing choroidal neovascularization

1 reference

12 December 2020

VEGF is major stimulator in model of choroidal neovascularization.

1 reference

12 December 2020

Global data on visual impairment in the year 2002

1 reference

12 December 2020

Prevalence of age-related macular degeneration in the United States

1 reference

12 December 2020

Neutrophils promote experimental choroidal neovascularization.

1 reference

12 December 2020

Age as an independent risk factor for severity of experimental choroidal neovascularization.

1 reference

12 December 2020

Ranibizumab: Phase III clinical trial results

1 reference

12 December 2020